Giorgio Chiaranda

Giorgio Chiaranda

Auto-generated profile, based on publicly available information

Giorgio Chiaranda

Department of Public Health, AUSL Piacenza, and Sport Medicine Service, 29121 Piacenza, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2018 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
Elisabetta TonetElisabetta Tonet
Elisabetta Tonet
EMElisa Maietti
Elisa Maietti
GCGiorgio Chiaranda
Giorgio Chiaranda
VFVitali Francesco
Vitali Francesco
MSMatteo Serenelli
Matteo Serenelli
GGGiovanni Grazzi
Giovanni Grazzi
Reduced physical performance and impaired mobility are common in elderly patients after acute coronary syndrome (ACS) and they represent independent risk factors for disability, morbidity, hospital readmission and mortality. Regular physical exercise represents a means for improving functional capacity. Nevertheless, its clinical benefit has been less investigated in elderly patients in the early phase after ACS. The HULK trial aims to investigate the clinical benefit of an early, tailored low-cost physical activity intervention in comparison to standard of care in elderly ACS patients with reduced physical performance. HULK is an investigator-initiated, prospective multicenter randomized controlled trial (NCT03021044). After successful management of the ACS acute phase and uneventful first 1 month, elderly (≥70 years) patients showing reduced physical performance are randomized (1:1 ratio) to either standard of care or physical activity intervention. Reduced physical performance is defined as a short physical performance battery (SPPB) score of 4–9. The early, tailored, low-cost physical intervention includes 4 sessions of physical activity with a supervisor and an home-based program of physical exercise. The chosen primary endpoint is the 6-month SPPB value. Secondary endpoints briefly include quality of life, on-treatment platelet reactivity, some laboratory data and clinical adverse events. To demonstrate an increase of at least one SPPB point in the experimental arm, a sample size of 226 patients is needed. The HULK study will test the hypothesis that an early, tailored low-cost physical activity intervention improves physical performance, quality of life, frailty status and outcome in elderly ACS patients with reduced physical performance. Clinicaltrials.gov, identifier NCT03021044 , first posted January, 13th 2017.

Verified
Journal Article
Open access
PDF file
Elisabetta TonetElisabetta Tonet
Elisabetta Tonet
RCRoberta Campana
Roberta Campana
SCSerena Caglioni
Serena Caglioni
FGFederico Gibiino
Federico Gibiino
AFAlessio Fiorio
Alessio Fiorio
Gianluca CampoGianluca Campo
Gianluca Campo
Malnutrition represents a common and important feature in elderly people affected by cardiovascular diseases. Several studies have investigated its prevalence and prognostic role in most clinical settings, including cardiovascular disease. However, in daily practice it usually remains unrecognized and consequently untreated. The present review was ideated to answer the main questions about nutritional status assessment in patients with cardiovascular disease: why, when, where, how to evaluate it, and what to do to improve it. The three main cardiovascular diseases, namely aortic stenosis, ischaemic heart disease, and heart failure were considered. First, the main evidence supporting the prognostic role of malnutrition are summarized and analyzed. Second, the main tools for the assessment of malnutrition in the hospital and outpatient setting are reported for each condition. Finally, the possible strategies and interventions to address malnutrition are discussed.

1 September 2017 in Journal of Cardiopulmonary Rehabilitation and Prevention
Verified
Journal Article
Closed access
PDF file
GGGiovanni Grazzi
Giovanni Grazzi
GCGiorgio Chiaranda
Giorgio Chiaranda
JMJonathan Myers
Jonathan Myers
GPGiovanni Pasanisi
Giovanni Pasanisi
RLRosario Lordi
Rosario Lordi
GMGianni Mazzoni
Gianni Mazzoni
The aim of this study was to determine whether the 1-km treadmill walking test, previously developed to predict peak oxygen uptake (VO2peak) in stable cardiac outpatients, could be reproduced outdoors. Fifty male cardiac outpatients performed the 1-km walking test on a treadmill and on a flat track within 1 week. VO2peak was estimated for both testing conditions considering age, height, weight, walking speed, and heart rate. Average walking speed was slightly higher during outdoor conditions (5.73 ± 0.77 km/h vs 5.55 ± 0.84 km/h), whereas mean heart rates were similar for both testing conditions (102 ± 18 beats/min vs 103 ± 16 beats/min). VO2peak values for treadmill and outdoor tests were not significantly different (26.4 ± 4.1 mL/kg/min vs 26.8 ± 4.5 mL/kg/min) and were strongly correlated (r = 0.93, P < .0001). The slope and the intercept of the VO2peak values were not different from the line of identity. This moderate and perceptually regulated 1-km walking test administered outdoors gives similar results compared with a similar test performed on a treadmill. Therefore, VO2peak can be reasonably estimated using both testing modalities. This suggests that the outdoor 1-km test can be applied for indirect estimations of cardiorespiratory fitness in an outpatient setting. In 50 cardiac outpatients, outdoor and treadmill 1-km walking tests provided similar results. Data derived from the outdoor 1-km test can be used to provide a reasonable estimate of VO2peak when evaluating cardiac outpatients.